Ibi Israel Biomedical Innovations, Ltd.
Country not established
- Devices
- 1
What Ibi Israel Biomedical Innovations, Ltd. makes
Ibi Israel Biomedical Innovations manufactures surgical stapling devices, including the ENDOFAST RELIANT SCP and ENDOFAST RELIANT LAP, designed for laparoscopic and open surgical procedures to seal tissue and vessels.
These devices are classified as Class II under FDA regulations and are listed via the 510(k) pathway. The company is based in the United States.
Catalogue
Endofast Reliant Scp, Endofast Reliant Lap Ref K130059
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Ibi Israel Biomedical Innovations, Ltd. have in the registry?
The registry currently lists 1 device for Ibi Israel Biomedical Innovations, Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Ibi Israel Biomedical Innovations, Ltd.'s devices?
Among its 1 most recently registered device, Ibi Israel Biomedical Innovations, Ltd. has devices listed in FDA 510(k) (1 device).
What risk classes do Ibi Israel Biomedical Innovations, Ltd.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Ibi Israel Biomedical Innovations, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Ibi Israel Biomedical Innovations, Ltd. in the registry?
The most recently registered devices listed for Ibi Israel Biomedical Innovations, Ltd. include ENDOFAST RELIANT SCP, ENDOFAST RELIANT LAP.